Ropes & Gray advised Sarepta Therapeutics on the deal.Sarepta Therapeutics, Inc. announced separate, privately negotiated exchange agreements with certain holders of its 1.50% Convertible Senior Notes…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now